Intra-peritoneal and intra-rectal immunogenicity induced by rotavirus virus like particles 2/6/7 in mice

Microbial Pathogenesis

Volumn 67-68, Issue 1, 2014, Pages 48-54

  Marashi, Sayed Mahdi ^a   Jalilvand, Somayeh ^a   Mollaei Kandelous, Yaghoub ^a   Shahmahmoodi, Shohreh ^a   Rezaei, Farhad ^a   Salimi, Vahid ^a   Nejati, Ahmad ^a   Validi, Majid ^b   Shoja, Zabihollah ^a,c  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHAHREKORD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c PASTEUR INSTITUTE OF IRAN   (Iran)

Author keywords

Antibody; Cytokine; VLP2 6 7

Indexed keywords

GAMMA INTERFERON; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; INTERLEUKIN 10; INTERLEUKIN 6; MESSENGER RNA; ROTAVIRUS VP2 PROTEIN; ROTAVIRUS VP6 PROTEIN; ROTAVIRUS VP7 PROTEIN; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ANIMAL EXPERIMENT; ANTIBODY BLOOD LEVEL; ARTICLE; CONTROLLED STUDY; CYTOKINE RESPONSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMORAL IMMUNITY; IMMUNIZATION; IMMUNOGENICITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; ROTAVIRUS; SPLEEN CELL; VIRUS LIKE AGENT;

ANTIBODY; CYTOKINE; VLP2/6/7;

ADMINISTRATION, RECTAL; ANIMALS; ANTIBODIES, VIRAL; ANTIGENS, VIRAL; CAPSID PROTEINS; FEMALE; IMMUNIZATION; INFUSIONS, PARENTERAL; INTERLEUKIN-10; INTERLEUKIN-6; MICE; MICE, INBRED BALB C; ROTAVIRUS; ROTAVIRUS INFECTIONS; VIRAL VACCINES;

EID: 84896049827     PISSN: 08824010     EISSN: 10961208     Source Type: Journal    
DOI: 10.1016/j.micpath.2014.02.005     Document Type: Article

References (61)

1. Bishop R.F., Davidson G.P., Holmes I.H., Ruck B.J. Virus particles in epithelial cells of duodenal mucosa from children with acute non-bacterial gastroenteritis. Lancet 1973, 2:1281-1283.
2. Bishop R.F., Davidson G.P., Holmes I.H., Ruck B.J. Detection of a new virus by electron microscopy of faecal extracts from children with acute gastroenteritis. Lancet 1974, 1(7849):149-151.
3. Kapikian A.Z., Kim H.W., Wyatt R.G., Rodriguez W.J., Ross S., Cline W.L., et al. Reoviruslike agent in stools: association with infantile diarrhea and development of serologic tests. Science 1974, 185(156):1049-1053.
4. Chen S.Y., Chiu C.H. Worldwide molecular epidemiology of norovirus infection. Paediatr Int Child Health 2012, 32(3):128-131.
5. Flewett T.H., Bryden A.S., Davies H. Letter: virus particles in gastroenteritis. Lancet 1973, 2:1497.
6. Bernstein D.I., Glass R.I., Rodgers G., Davidson B.L., Sack D.A. Evaluation of rhesus rotavirus monovalent and tetravalent reassortant vaccines in US children. US Rotavirus Vaccine Efficacy Group. JAMA 1995, 273(15):1191-1196.
7. Murphy B.R., Morens D.M., Simonsen L., Chanock R.M., La M., Kapikian A.Z. Reappraisal of the association of intussusception with the licensed live rotavirus vaccine challenges initial conclusions. JInfect Dis 2003, 187(8):1301-1308.
8. Murphy T.V., Gargiullo P.M., Massoudi M.S., Nelson D.B., Jumaan A.O., Okoro C.A., et al. Intussusception among infants given an oral rotavirus vaccine. NEngl J Med 2001, 344(8):564-572.
9. Bernstein D.I., Smith V.E., Sherwood J.R., Schiff G.M., Sander D.S., DeFeudis D., et al. Safety and immunogenicity of live, attenuated human rotavirus vaccine 89-12. Vaccine 1998, 16(4):381-387.
10. Bernstein D.I., Sack D.A., Rothstein E., Reisinger K., Smith V.E., O'Sullivan D., et al. Efficacy of live, attenuated, human rotavirus vaccine 89-12 in infants: a randomised placebo-controlled trial. Lancet 1999, 354(9175):287-290.
11. Vesikari T., Clark H.F., Offit P.A., Dallas M.J., DiStefano D.J., Goveia M.G., et al. Effects of the potency and composition of the multivalent human-bovine (WC3) reassortant rotavirus vaccine on efficacy, safety and immunogenicity in healthy infants. Vaccine 2006, 24(22):4821-4829.
12. Ruiz-Palacios G.M., Perez-Schael I., Velazquez F.R., Abate H., Breuer T., Clemens S.C., et al. Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. NEngl J Med 2006, 354(1):11-22.
13. Vesikari T., Matson D.O., Dennehy P., Van D.P., Santosham M., Rodriguez Z., et al. Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. NEngl J Med 2006, 354(1):23-33.
14. Parez P. Rotavirus gastroenteritis: why to back up the development of new vaccines?. Comp Immun Microbiol Infect Dis 2008, 31:253-269.
15. Ward R.L., McNeal M.M., Steele A.D. Why does the world need another rotavirus vaccine?. Ther Clin Risk Manag 2008, 4(1):49-63.
16. Jiang B., Wang Y., Glass R.I. Does a monovalent inactivated human rotavirus vaccine induce heterotypic immunity? Evidence from animal studies. Hum Vaccin Immunother 2013, 9(8):1634-1637.
17. Jiang B., Gentsch J.R., Glass R.I. Inactivated rotavirus vaccines: a priority for accelerated vaccine development. Vaccine 2008, 26(52):6754-6758.
18. Wang Y., Azevedo M., Saif L.J., Gentsch J.R., Glass R.I., Jiang B. Inactivated rotavirus vaccine induces protective immunity in gnotobiotic piglets. Vaccine 2010, 28(33):5432-5436.
19. Zeng C.Q., Labbe M., Cohen J., Prasad B.V., Chen D., Ramig R.F., et al. Characterization of rotavirus VP2 particles. Virology 1994, 201(1):55-65.
20. Molinari P., Peralta A., Taboga O. Production of rotavirus-like particles in Spodoptera frugiperda larvae. JVirol Methods 2008, 147(2):364-367.
21. Mena J.A., Ramirez O.T., Palomares L.A. Intracellular distribution of rotavirus structural proteins and virus-like particles expressed in the insect cell-baculovirus system. JBiotechnol 2006, 122(4):443-452.
22. Mena J.A., Ramirez O.T., Palomares L.A. Population kinetics during simultaneous infection of insect cells with two different recombinant baculoviruses for the production of rotavirus-like particles. BMC Biotechnol 2007, 7:39.
23. Labbe M., Charpilienne A., Crawford S.E., Estes M.K., Cohen J. Expression of rotavirus VP2 produces empty corelike particles. JVirol 1991, 65(6):2946-2952.
24. Kim Y., Chang K.O., Kim W.Y., Saif L.J. Production of hybrid double- or triple-layered virus-like particles of group A and C rotaviruses using a baculovirus expression system. Virology 2002, 302(1):1-8.
25. Jiang B., Barniak V., Smith R.P., Sharma R., Corsaro B., Hu B., et al. Synthesis of rotavirus-like particles in insect cells: comparative and quantitative analysis. Biotechnol Bioeng 1998, 60(3):369-374.
26. Gonzalez S.A., Affranchino J.L. Assembly of double-layered virus-like particles in mammalian cells by coexpression of human rotavirus VP2 and VP6. JGen Virol 1995, 76(Pt 9):2357-2360.
27. Crawford S.E., Labbe M., Cohen J., Burroughs M.H., Zhou Y.J., Estes M.K. Characterization of virus-like particles produced by the expression of rotavirus capsid proteins in insect cells. JVirol 1994, 68(9):5945-5952.
28. Charpilienne A., Nejmeddine M., Berois M., Parez N., Neumann E., Hewat E., et al. Individual rotavirus-like particles containing 120 molecules of fluorescent protein are visible in living cells. JBiol Chem 2001, 276(31):29361-29367.
29. Agnello D., Herve C.A., Lavaux A., Darniot M., Guillon P., Charpilienne A., et al. Intrarectal immunization with rotavirus 2/6 virus-like particles induces an antirotavirus immune response localized in the intestinal mucosa and protects against rotavirus infection in mice. JVirol 2006, 80(8):3823-3832.
30. Bertolotti-Ciarlet A., Ciarlet M., Crawford S.E., Conner M.E., Estes M.K. Immunogenicity and protective efficacy of rotavirus 2/6-virus-like particles produced by a dual baculovirus expression vector and administered intramuscularly, intranasally, or orally to mice. Vaccine 2003, 21(25-26):3885-3900.
31. Crawford S.E., Estes M.K., Ciarlet M., Barone C., O'Neal C.M., Cohen J., et al. Heterotypic protection and induction of a broad heterotypic neutralization response by rotavirus-like particles. JVirol 1999, 73(6):4813-4822.
32. Fromantin C., Jamot B., Cohen J., Piroth L., Pothier P., Kohli E. Rotavirus 2/6 virus-like particles administered intranasally in mice, with or without the mucosal adjuvants cholera toxin and Escherichia coli heat-labile toxin, induce a Th1/Th2-like immune response. JVirol 2001, 75(22):11010-11016.
33. Istrate C., Hinkula J., Charpilienne A., Poncet D., Cohen J., Svensson L., et al. Parenteral administration of RF 8-2/6/7 rotavirus-like particles in a one-dose regimen induce protective immunity in mice. Vaccine 2008, 26(35):4594-4601.
34. Parez N., Fourgeux C., Mohamed A., Dubuquoy C., Pillot M., Dehee A., et al. Rectal immunization with rotavirus virus-like particles induces systemic and mucosal humoral immune responses and protects mice against rotavirus infection. JVirol 2006, 80(4):1752-1761.
35. Shuttleworth G., Eckery D.C., Awram P. Oral and intraperitoneal immunization with rotavirus 2/6 virus-like particles stimulates a systemic and mucosal immune response in mice. Arch Virol 2005, 150(2):341-349.
36. Choi A.H., McNeal M.M., Basu M., Flint J.A., Stone S.C., Clements J.D., et al. Intranasal or oral immunization of inbred and outbred mice with murine or human rotavirus VP6 proteins protects against viral shedding after challenge with murine rotaviruses. Vaccine 2002, 20(27-28):3310-3321.
37. VanCott J.L., Prada A.E., McNeal M.M., Stone S.C., Basu M., Huffer B., et al. Mice develop effective but delayed protective immune responses when immunized as neonates either intranasally with nonliving VP6/LT(R192G) or orally with live rhesus rotavirus vaccine candidates. JVirol 2006, 80(10):4949-4961.
38. McNeal M.M., Stone S.C., Basu M., Bean J.A., Clements J.D., Hendrickson B.A., et al. Protection against rotavirus shedding after intranasal immunization of mice with a chimeric VP6 protein does not require intestinal IgA. Virology 2006, 346(2):338-347.
39. Kim Y., Nielsen P.R., Hodgins D., Chang K.O., Saif L.J. Lactogenic antibody responses in cows vaccinated with recombinant bovine rotavirus-like particles (VLPs) of two serotypes or inactivated bovine rotavirus vaccines. Vaccine 2002 Jan 15, 20(7-8):1248-1258.
40. Murata K., Lechmann M., Qiao M., Gunji T., Alter H.J., Liang T.J. Immunization with hepatitis C virus-like particles protects mice from recombinant hepatitis C virus-vaccinia infection. Proc Natl Acad Sci U S A 2003 May 27, 100(11):6753-6758.
41. Quan F.S., Yoo D.G., Song J.M., Clements J.D., Compans R.W., Kang S.M. Kinetics of immune responses to influenza virus-like particles and dose-dependence of protection with a single vaccination. JVirol 2009 May, 83(9):4489-4497.
42. Noad R., Roy P. Virus-like particles as immunogens. Trends Microbiol 2003, 11(9):438-444.
43. Alkadah A., Thiam F., Mounier M., Charpilienne A., Poncet D., Kohli E., et al. Different profile and distribution of antigen specific T cells induced by intranasal and intrarectal immunization with rotavirus 2/6-VLP with and without LT-R192G. Vaccine 2013, 31(15):1924-1930.
44. Buonaguro L., Buonaguro F.M., Tornesello M.L., Mantas D., Beth-Giraldo E., Wagner R., et al. High efficient production of Pr55(gag) virus-like particles expressing multiple HIV-1 epitopes, including a gp120 protein derived from an Ugandan HIV-1 isolate of subtype A. Antiviral Res 2001, 49(1):35-47.
45. Rovinski B., Haynes J.R., Cao S.X., James O., Sia C., Zolla-Pazner S., et al. Expression and characterization of genetically engineered human immunodeficiency virus-like particles containing modified envelope glycoproteins: implications for development of a cross-protective AIDS vaccine. JVirol 1992, 66(7):4003-4012.
46. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001, 25(4):402-408.
47. Parashar U.D., Gibson C.J., Bresse J.S., Glass R.I. Rotavirus and severe childhood diarrhea. Emerg Infect Dis 2006, 12(2):304-306.
48. Tate J.E., Burton A.H., Boschi-Pinto C., Steele A.D., Duque J., Parashar U.D. 2008 estimate of worldwide rotavirus-associated mortality in children younger than 5 years before the introduction of universal rotavirus vaccination programmes: a systematic review and meta-analysis. Lancet Infect Dis 2011, 12(2):136-141.
49. Glass R.I. Perceived threats and real killers. Science 2004, 304(5673):927.
50. Rennels M.B., Glass R.I., Dennehy P.H., Bernstein D.I., Pichichero M.E., Zito E.T., et al. Safety and efficacy of high-dose rhesus-human reassortant rotavirus vaccines - report of the National Multicenter Trial. United States Rotavirus Vaccine Efficacy Group. Pediatrics 1996, 97(1):7-13.
51. Conner M.E., Crawford S.E., Barone C., Estes M.K. Rotavirus vaccine administered parenterally induces protective immunity. JVirol 1993 Nov, 67(11):6633-6641.
52. Conner M.E., Zarley C.D., Hu B., Parsons S., Drabinski D., Greiner S., et al. Virus-like particles as a rotavirus subunit vaccine. JInfect Dis 1996 Sep, 174(Suppl.1):S88-S92.
53. McNeal M.M., Sheridan J.F., Ward R.L. Active protection against rotavirus infection of mice following intraperitoneal immunization. Virology 1992 Nov, 191(1):150-157.
54. O'Neal C.M., Crawford S.E., Estes M.K., Conner M.E. Rotavirus virus-like particles administered mucosally induce protective immunity. JVirol 1997, 71(11):8707-8717.
55. Zhou H., Guo L., Wang M., Qu J., Zhao Z., Wang J., et al. Prime immunization with rotavirus VLP 2/6 followed by boosting with an adenovirus expressing VP6 induces protective immunization against rotavirus in mice. Virol J 2011, 8:3.
56. Choi A.H., McNeal M.M., Flint J.A., Basu M., Lycke N.Y., Clements J.D., et al. The level of protection against rotavirus shedding in mice following immunization with a chimeric VP6 protein is dependent on the route and the coadministered adjuvant. Vaccine 2002, 20(13-14):1733-1740.
57. O'Neal C.M., Clements J.D., Estes M.K., Conner M.E. Rotavirus 2/6 viruslike particles administered intranasally with cholera toxin, Escherichia coli heat-labile toxin (LT), and LT-R192G induce protection from rotavirus challenge. JVirol 1998, 72(4):3390-3393.
58. Fromantin C., Piroth L., Petitpas I., Pothier P., Kohli E. Oral delivery of homologous and heterologous strains of rotavirus to BALB/c mice induces the same profile of cytokine production by spleen cells. Virology 1998, 244(2):252-260.
59. Azim T., Zaki M.H., Podder G., Sultana N., Salam M.A., Rahman S.M., et al. Rotavirus-specific subclass antibody and cytokine responses in Bangladeshi children with rotavirus diarrhoea. JMed Virol 2003, 69(2):286-295.
60. Xu J., Yang Y., Sun J., Ding Y., Su L., Shao C., et al. Expression of Toll-like receptors and their association with cytokine responses in peripheral blood mononuclear cells of children with acute rotavirus diarrhoea. Clin Exp Immunol 2006, 144(3):376-381.
61. Yu T.H., Tsai C.N., Lai M.W., Chen C.C., Chao H.C., Lin C.W., et al. Antigenemia and cytokine expression in rotavirus gastroenteritis in children. JMicrobiol Immunol Infect 2012, 45(4):265-270.